Kim Lorence H.

Director at RVMD; Chief Financial Officer at MRNA

Sold, on record
$86.5M
Dollars the filings state
Form 4 sales
14
Latest Sep 8, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • RVMDRevolution Medicines, Inc.Director
  • MRNAModerna, Inc.Chief Financial Officer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale MRNAPlan not stated
    Mar 16, 2020 2020

    Sold 20,000 shares at $26.19 ($524k)

    Kim Lorence H., Chief Financial Officer

    Sold 1.6% of holdings ($33.1M position)1.2M shares left0.9x usual sizeFiling

  2. 2 Form 4 sale MRNAPlan not stated
    Apr 15, 2020 +30 days

    Sold 20,000 shares at $36.21 ($724k)

    Kim Lorence H., Chief Financial Officer

    Sold 1.6% of holdings ($45M position)1.2M shares left1x usual sizeFiling

  3. 3 Form 4 sale MRNAUnusual
    May 12, 2020 +27 days

    Sold 241,000 shares at $64.49 ($15.5M)

    Kim Lorence H., Chief Financial Officer

    Sold 16.5% of holdings ($94.4M position)1.2M shares left12.1x usual sizeFiling

  4. 4 Form 4 sale MRNAUnusual
    May 18, 2020 +6 days

    Sold 261,000 shares at $80.85 ($21.1M)

    Kim Lorence H., Chief Financial Officer

    Sold 17.8% of holdings ($118M position)1.2M shares left13.1x usual sizeFiling

  5. 5 Form 4 sale MRNAUnusual
    May 27, 2020 +9 days

    Sold 241,000 shares at $51.13 ($12.3M)

    Kim Lorence H., Chief Financial Officer

    Sold 16.7% of holdings ($73.8M position)1.2M shares left10.8x usual sizeFiling

  6. 6 Form 4 sale MRNAUnusual
    Jun 2, 2020 +6 days

    Sold 241,000 shares at $58.30 ($14.1M)

    Kim Lorence H., Chief Financial Officer

    Sold 16.7% of holdings ($84.2M position)1.2M shares left9.8x usual sizeFiling

  7. 7 Form 4 sale RVMDRoutine
    Aug 31, 2026 +2281 days

    Sold 56,000 shares at $203.24 ($11.4M)

    Kim Lorence H., Director

    10b5-1 planSold 76.6% of holdings ($14.9M position)17,090 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale RVMDRoutine
    Sep 8, 2026 +8 days

    Sold 17,090 shares at $209.82 ($3.6M)

    Kim Lorence H., Director

    10b5-1 planSold 100% of holdings ($3.6M position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Kim Lorence H.
Source
Sep 8, 2026Sep 10, 2026RVMDDirectorForm 4 sale17,090$3.6M100.0%RoutineSEC
Aug 31, 2026Sep 2, 2026RVMDDirectorForm 4 sale56,000$11.4M76.6%RoutineSEC
Jun 2, 2020Jun 4, 2020MRNAChief Financial OfficerForm 4 sale241,000$14.1M16.7%UnusualSEC
May 27, 2020May 28, 2020MRNAChief Financial OfficerForm 4 sale241,000$12.3M16.7%UnusualSEC
May 18, 2020May 19, 2020MRNAChief Financial OfficerForm 4 sale261,000$21.1M17.8%UnusualSEC
May 12, 2020May 14, 2020MRNAChief Financial OfficerForm 4 sale241,000$15.5M16.5%UnusualSEC
Apr 15, 2020Apr 16, 2020MRNAChief Financial OfficerForm 4 sale20,000$724k1.6%Plan not statedSEC
Mar 16, 2020Mar 18, 2020MRNAChief Financial OfficerForm 4 sale20,000$524k1.6%Plan not statedSEC
Mar 4, 2020Mar 6, 2020MRNAChief Financial OfficerForm 4 sale20,000$554k1.6%Plan not statedSEC
Feb 26, 2020Feb 27, 2020MRNAChief Financial OfficerForm 4 sale20,000$568k1.5%Plan not statedSEC
Feb 7, 2020Feb 11, 2020MRNAChief Financial OfficerForm 4 sale33,295$768k2.5%Plan not statedSEC
Jan 28, 2020Jan 29, 2020MRNAChief Financial OfficerForm 4 sale24,705$569k1.8%Plan not statedSEC
Jan 22, 2020Jan 23, 2020MRNAChief Financial OfficerForm 4 sale2,000$46k0.1%Plan not statedSEC
Dec 6, 2019Dec 9, 2019MRNAChief Financial OfficerForm 4 sale238,532$4.8M14.9%Plan not statedSEC